INFUSION REACTION

Clinical trials for INFUSION REACTION explained in plain language.

Never miss a new study

Get alerted when new INFUSION REACTION trials appear

Sign up with your email to follow new studies for INFUSION REACTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1 Completed 1

New approach aims to make tough lung cancer treatment more tolerable

Disease control Not yet recruiting

This study is testing whether a comprehensive prevention plan can help Chinese patients with advanced lung cancer better tolerate treatment with the drug amivantamab. The plan aims to reduce common side effects like skin rash, infusion reactions, and blood clots. Researchers will…

Matched conditions: INFUSION REACTION

Phase: PHASE4 • Sponsor: Shanghai Pulmonary Hospital, Shanghai, China • Aim: Disease control

Last updated Mar 30, 2026 14:28 UTC

INFUSION REACTION

Get alerted when new INFUSION REACTION trials appear

New approach aims to make tough lung cancer treatment more tolerable